Announcements Trials
Browse Landscape

Phase

Phase 2 55Phase 1 52Phase NA 50Phase 1/2 47Phase 3 9Phase EARLY_PHASE1 8Phase 2/3 6Phase 4 2

Status

Completed 16Unknown 13Recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 33Neoplasms 16Prostatic Neoplasms 15Lung Neoplasms 11Carcinoma, Hepatocellular 11Multiple Myeloma 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Papillomavirus Infections 6Pain, Postoperative 6Neoplasm Metastasis 6Liver Neoplasms 6Leukemia, Myeloid, Acute 6Stomach Neoplasms 5Recurrence 5Lymphoma, Non-Hodgkin 4Kidney Neoplasms 4Heart Failure 4Glioma 4Febrile Neutropenia 4Carcinoma, Renal Cell 4Brain Neoplasms 4Warts 3Vomiting 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Skin Neoplasms 3Rectal Neoplasms 3Pituitary Neoplasms 3

Interventions

fluarix 1arexvy 1abrysvo 1Vinblastine 1Influenza Vaccines 1Heplisav-B 1FluLaval 1Doxorubicin 1Dacarbazine 1Brentuximab Vedotin 1BNT162 Vaccine 1Afluria 123-valent pneumococcal capsular polysaccharide vaccine 113-valent pneumococcal vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Lymphoma × Clear all
NCT06831370 2026-02-23

A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Takeda

Phase 4 Recruiting
124 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting
500 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡